IMRT and image-guided adapted brachytherapy for cervix cancer

IMRT and 3D image-guided adapted brachytherapy (3D-IGABT) is increasingly used for definitive cervical cancer treatment. We compared patterns of failure and survival to patients treated with 2D external beam radiation and brachytherapy, with all patients receiving a pre-treatment PET and all surviving patients having 5 years minimum follow up. IMRT and 3D-IGABT was associated with higher survival and reduced late bowel and bladder toxicities.

Source: International Journal of Radiation Oncology * Biology * Physics - November 13, 2018 Category: Radiology Authors: Alexander J. Lin, Elizabeth Kidd, Farrokh Dehdashti, Barry A. Siegel, Sasa Mutic, Premal H. Thaker, Leslie S. Massad, Matthew A. Powell, David G. Mutch, Stephanie Markovina, Julie Schwarz, Perry W. Grigsby Tags: Clinical Investigation Source Type: research